48
Participants
Start Date
December 5, 2022
Primary Completion Date
December 17, 2024
Study Completion Date
December 17, 2024
mRNA-0184
mRNA-0184 dispersion for intravenous (IV) infusion
Placebo
0.9% sodium chloride (normal saline) injection
Jacksonville Center For Clinical Research - ERN - PPDS, Jacksonville
University of Florida, Gainesville
Cardiology PC, Birmingham
University of Alabama at Birmingham: The Kirklin Clinic, Birmingham
Tennessee Center for Clinical Trials, Tullahoma
Uniwersytecki Szpital Kliniczny w Poznaniu, Poznan
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego we Wroclawiu, Wroclaw
Uniwersytecki Szpital Kliniczny w Bialymstoku, Bialystok
Gornoslaskie Centrum Medyczne im. prof. Leszka Gieca Slasiego Uniwersytetu Medycznego w Katowicach, Katowice
Ninewells Hospital & Medical School, Dundee
Addenbrooke's Hospital, Cambridge
University College Hospital, London
Derriford Hospital, Plymouth
The Royal Liverpool University Hospital, Liverpool
ModernaTX, Inc.
INDUSTRY